Ilyang Pharmaceutical Co.,Ltd (007575.KS) KSC

12,980.00

+140(+1.09%)

Updated at September 12, 2025 07:47AM

Currency In KRW

Valuation

Market Cap210.12B
Enterprise Value313.5B
P/E Ratio14.8
PEG Ratio0.34
Price/Sales Ratio1.16
Price/Book Ratio0.99
Enterprise/Revenue1.7
Enterprise/EBITDA8.78

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.02

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue268.86B
Revenue/Share10,966.96
Gross Profit111.48B
EBITDA25.03B
Net Income10.26B
Diluted EPS557

Balance Sheet

Total Cash15.49B
Total Cash/Share841.01
Total Debt119.48B
Total Debt/Equity0.49
Current Ratio0.94
Book Value Per Share13,451.92

Price History

52-Week Change7.18
52-Week High16,500
52-Week Low9,470
Moving Average 50 Days13,690.2
Moving Average 200 Days12,117.35

Statistics

Average Volume947
Shares Outstanding18.17M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate155
Trailing Annual Dividend Yield1.19
Payout Ratio0.13
Last Split Factor2:1
Last Split DateJune 28, 2006